Study: BCG administration promotes the long-term protection afforded by a single-dose intranasal adenovirus-based SARS-CoV-2 vaccine.Image Credit: Tama2u/Shutterstock *Important notice: bioRxiv ...

ImmunityBio Requests an Urgent Meeting With FDA to Address the Change in the Agency’s Unambiguous Guidance on Jan 2025 to Submit a sBLA for NMIBC BCG Unresponsive Papillary Disease, Following an ...

BCG’s total revenues climbed just 5 per cent in 2023 to $12.3bn, the firm’s weakest growth in at least seven years. However, Schweizer said the consulting market “feels more positive ...

Multiple BCG vaccinations for prevention of COVID-19 and other infectious diseases in Type 1 diabetes. Cell Reports Medicine , 2022; 100728 DOI: 10.1016/j.xcrm.2022.100728 Cite This Page : ...

CIS with or without Papillary: Oral presentation from QUILT-3.032 study showed 71% complete response rate (N=100), with duration of response ranging up to more than 53 months, in BCG-unresponsive ...